Biomerica (BMRA) Deferred Taxes (2010 - 2016)

Biomerica (BMRA) posted Deferred Taxes of -$957000.0 for Q2 2016, down 865.6% sequentially from $125000.0 in Q1 2016.

Biomerica (BMRA) Deferred Taxes (2010 - 2016) Analysis & Trends

Biomerica has reported Deferred Taxes for 3 years, with the latest figure at -$957000.0 in Q2 2016.

Quarterly Deferred Taxes changed N/A year-over-year to -$957000.0 in Q2 2016, while the trailing twelve-month figure through May 2016 was -$830446.0 (changed N/A YoY) and the FY2019 annual result came in at -$10000.0, up 67.74% from the prior year.
Deferred Taxes slipped to -$957000.0 in Q2 2016 per BMRA's latest filing, from $125000.0 in the prior quarter.
Over five years, Deferred Taxes peaked at $125000.0 in Q1 2016 and troughed at -$957000.0 in Q2 2016.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Deferred Taxes (Qtr)
1	Abbott Laboratories	202.34 Bn	196.74 Bn	7.27 Bn	-
2	Stryker	125.99 Bn	122.52 Bn	4.50 Bn	107.00 Mn
3	Medtronic	119.32 Bn	110.10 Bn	6.41 Bn	-8.00 Mn
4	Boston Scientific	74.13 Bn	73.60 Bn	3.85 Bn	17.00 Mn
5	Edwards Lifesciences	51.73 Bn	47.47 Bn	1.35 Bn	-181.30 Mn
6	Dexcom	35.18 Bn	33.23 Bn	830.00 Mn	-300,000.00
7	GE HealthCare Technologies	33.81 Bn	31.70 Bn	2.18 Bn	-
8	Koninklijke Philips	26.20 Bn	22.88 Bn	4.55 Bn	235.96 Mn
9	Steris	23.20 Bn	22.72 Bn	684.20 Mn	600,000.00
10	Biomerica	4.86 Mn	3.53 Mn	-44,000.00	-

Download Data